Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Sickle Cell
•
Pediatric Hematology
•
Benign Hematology
•
Stem Cell Transplantation
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
Answer from: at Academic Institution
All patients with Hgb SS and patients with Hgb SC who have had any significant complications, excluding chronic pain.
Sign in or Register to read more
22690
Related Questions
What would your next line of treatment be for a patient with Hb SC with history of recurrent VOC and new bone infarct who is already on hydroxyurea and phlebotomy?
Is there any indication for hydroxyurea in patients with sickle cell trait?
Is it true that a ferritin above 200 essentially rules out iron deficiency?
How do you interpret a low VWF activity/antigen ratio, when both activity and antigen levels are above 50%?
What is your target Hgb/Hct for women who are pregnant and have sickle cell disease in whom you are doing scheduled transfusions?
What is your strategy for optimizing hydroxyurea dosage in patients with symptomatic sickle cell disease, particularly for genotypes HbSS and HbS/Beta thal?
Are SCDs contraindicated in patients with acute DVTs?
What is the ideal period to wait until curative surgery for patients with acute pulmonary embolism and solid malignancy?
Do you screen children with sickle cell disease for silent cerebral infarcts?
For a patient with May-Thurner syndrome and DVT, would you recommend anticoagulation for 3-6 months or indefinitely?